Free Trial

Bank Julius Baer & Co. Ltd Zurich Has $19.12 Million Stock Holdings in Veeva Systems Inc. (NYSE:VEEV)

Veeva Systems logo with Medical background

Bank Julius Baer & Co. Ltd Zurich decreased its stake in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 4.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 75,951 shares of the technology company's stock after selling 3,820 shares during the period. Bank Julius Baer & Co. Ltd Zurich's holdings in Veeva Systems were worth $19,124,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Abound Financial LLC purchased a new position in shares of Veeva Systems in the first quarter worth approximately $25,000. ORG Partners LLC acquired a new stake in shares of Veeva Systems during the first quarter worth approximately $26,000. Golden State Wealth Management LLC boosted its holdings in shares of Veeva Systems by 152.9% during the first quarter. Golden State Wealth Management LLC now owns 129 shares of the technology company's stock worth $30,000 after purchasing an additional 78 shares during the period. Wayfinding Financial LLC acquired a new stake in shares of Veeva Systems during the first quarter worth approximately $32,000. Finally, Key Financial Inc boosted its holdings in shares of Veeva Systems by 161.0% during the first quarter. Key Financial Inc now owns 154 shares of the technology company's stock worth $36,000 after purchasing an additional 95 shares during the period. Institutional investors and hedge funds own 88.20% of the company's stock.

Insider Transactions at Veeva Systems

In other news, SVP Jonathan Faddis sold 720 shares of the firm's stock in a transaction that occurred on Thursday, July 10th. The shares were sold at an average price of $285.62, for a total transaction of $205,646.40. Following the completion of the transaction, the senior vice president directly owned 7,902 shares of the company's stock, valued at $2,256,969.24. This trade represents a 8.35% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Priscilla Hung sold 172 shares of the firm's stock in a transaction that occurred on Thursday, July 3rd. The stock was sold at an average price of $283.00, for a total transaction of $48,676.00. Following the transaction, the director directly owned 4,137 shares of the company's stock, valued at $1,170,771. This represents a 3.99% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,378 shares of company stock valued at $394,217 in the last ninety days. 10.30% of the stock is currently owned by corporate insiders.

Veeva Systems Stock Performance

NYSE VEEV traded up $0.07 during trading hours on Friday, reaching $291.32. 812,033 shares of the company's stock were exchanged, compared to its average volume of 1,327,348. The company's 50-day moving average is $274.08 and its two-hundred day moving average is $243.73. Veeva Systems Inc. has a one year low of $177.41 and a one year high of $294.00. The company has a market capitalization of $47.60 billion, a price-to-earnings ratio of 61.71, a price-to-earnings-growth ratio of 2.27 and a beta of 0.98.

Veeva Systems (NYSE:VEEV - Get Free Report) last posted its earnings results on Wednesday, May 28th. The technology company reported $1.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.74 by $0.23. The business had revenue of $759.04 million during the quarter, compared to analysts' expectations of $728.38 million. Veeva Systems had a return on equity of 13.96% and a net margin of 27.34%. Veeva Systems's revenue for the quarter was up 16.7% compared to the same quarter last year. During the same period in the prior year, the business earned $1.50 EPS. Research analysts predict that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

VEEV has been the subject of several research reports. Mizuho raised their price target on shares of Veeva Systems from $280.00 to $295.00 and gave the stock an "outperform" rating in a report on Monday, June 2nd. Citigroup lifted their target price on shares of Veeva Systems from $265.00 to $329.00 and gave the company a "buy" rating in a research note on Friday, May 30th. Truist Financial lifted their target price on shares of Veeva Systems from $217.00 to $230.00 and gave the company a "hold" rating in a research note on Thursday, May 29th. Barclays lifted their target price on shares of Veeva Systems from $285.00 to $300.00 and gave the company an "overweight" rating in a research note on Thursday, May 29th. Finally, UBS Group lifted their target price on shares of Veeva Systems from $250.00 to $285.00 and gave the company a "neutral" rating in a research note on Thursday, May 29th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, Veeva Systems currently has an average rating of "Moderate Buy" and a consensus price target of $274.17.

Read Our Latest Analysis on Veeva Systems

About Veeva Systems

(Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Featured Stories

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

Should You Invest $1,000 in Veeva Systems Right Now?

Before you consider Veeva Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.

While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines